[EpochTimesJuly292021]On July 22, the spokesperson of the Ministry of Foreign Affairs of the Communist Party of China, Zhao Lijian, in a regular press conference, citing a statement issued by Sri Jayawardenepura University two days ago about China National Medicines The vaccine effectiveness research report stated that 95% of the population can produce antibodies after being vaccinated with two doses of the Sinopharm vaccine, and 81.25% of the population can induce the production of neutralizing antibodies. In addition, the study also found that the Sinopharm vaccine is very effective against the new crown variant strain Delta (Delta). Therefore, Zhao Lijian proudly said that this fully shows that the Chinese vaccine is effective and safe.
The CCP’s statement was issued in Hungary and some countries in Southeast Asia after the vaccines produced by the CCP were ineffective, and they switched to European and American vaccines. Previously, in Indonesia, Thailand, Mongolia and other countries, many people who received two injections of Sinopharm and Coxing vaccine were infected, and some medical staff unfortunately passed away. In addition, according to Western media reports, the effectiveness of Chinese vaccines is far lower than that of Western countries’ mRNA vaccines. A Brazilian study found that the effectiveness of Coxing vaccine in preventing viral infections is as low as 50.4%, which is close to the 50% minimum threshold recognized by health experts. In comparison, the effective rate of Pfizer vaccine is around 97%.
If the Chinese people are ignorant, unbelieving or indifferent to the reaction of other countries under the brainwashing of the CCP, then the recent outbreak of the epidemic in Nanjing and the change of the face of the Pfizer vaccine into China will severely hit the CCP authorities.
According to mainland media reports, on July 28, the Nanjing Municipal Government announced that the number of confirmed cases of the new wave of epidemics reached 153, including 4 cases of severe illness. The known infected persons include not only the family members and relatives of airport staff but also community residents and colleges and universities. Resident management, individual industrial and commercial households, taxi drivers, etc. After the outbreak of the epidemic, the Nanjing municipal government closed several communities and screened them through a new round of full-staff testing. The virus strain that caused the epidemic in Nanjing was Delta.
According to Ding Jie, deputy director of the Nanjing Centers for Disease Control and Prevention, stated at a press conference on epidemic prevention and control on the 27th, this mutant strain currently has some new characteristics. The amount is relatively high, and the treatment time is long, and it is easier to develop into severe illness.
Not only that, the out-of-control epidemic in Nanjing has spread to many provinces, including Suqian in Jiangsu, Hexian in Anhui, Wuhu in Anhui, Shenyang in Liaoning, Dalian in Liaoning, Zhongshan in Guangdong, Zhuhai in Guangdong, Mianyang in Sichuan, and Shanghai. It is not surprising that there will be epidemics in other provinces in the future.
As the Nanjing epidemic worsened and spread, the Chinese Communist Party’s Health Commission announced that as of July 25, the Chinese had received 1.55 billion doses of vaccines, exceeding the total population of China, including the absolute number of people in Nanjing and surrounding areas. Most of the population.
According to mainland media reports, the Nanjing Lukou Airport, where the epidemic first broke out, is one of the member units of the Eastern Airport Group. As of May 12, the total number of people vaccinated by the Eastern Airport Group was 9,251, and the vaccination rate reached 90.87%. Among them, Nanjing Airport organized a total of 29 vaccinations for its employees, and a total of 5,036 people were vaccinated. The vaccination rate reached 90.3%. It is reported that most of the new infections have been vaccinated twice.
Undoubtedly, the data from the National Health Commission and Nanjing Airport are clearly telling people that Chinese vaccines have limited effectiveness in preventing the spread of the epidemic. The spokesperson of the Ministry of Foreign Affairs of the Communist Party of China just said that domestic vaccines are effective and very effective for Delta. lie. The CCP’s face was hit again.
In addition, a piece of news shortly before the outbreak of the epidemic in Nanjing is very interesting. On July 14, Shanghai Fosun Pharma said in response to investor inquiries at the shareholders meeting that the China National Medical Products Administration has basically completed the review of the mRNA new crown vaccine “Fubitai”, and the expert review has been passed and is currently stepping up The administrative approval stage is carried out. Fosun Pharma has started production preparations in advance with BioNTech of Germany and Pfizer of the United States. Once approved, Fubitel vaccine can be supplied to the country as soon as possible. People familiar with the matter said that in the future, Fubitai is likely to be used as an intensified injection in China, with free vaccination.
Fubitai is the trade name of the mRNA new crown vaccine BNT162b2 developed by the German vaccine company BioNTech in mainland China, Hong Kong and Macau. In March 2020, this German company successively signed an agreement with Fosun Pharma and American pharmaceutical company Pfizer to jointly develop and commercialize mRNA vaccines. Fosun Pharma has the exclusive agency rights for the vaccine in mainland China, Hong Kong, Macau and Taiwan, and Pfizer is responsible The rest of the world. In other words, Fubitai is the name of Pfizer Vaccine in China. In May of this year, Fosun Pharma issued an announcement stating that it will realize the localized production and commercialization of mRNA vaccine products, with an annual production capacity of up to 1 billion doses.
The external signal of the above information is that after the Chinese have received 1.5 billion doses of fire-fighting vaccines, it is very likely that Fubitai will be used as a booster shot. Isn’t this disproving the lack of China’s vaccine protection capabilities?
So, can vaccination with booster shots prevent the virus? Are there any unknown side effects of mixing the two vaccines? At present, after the emergence of mutated viruses, the protective effects of Pfizer vaccines have dropped significantly. According to data from the Israeli Ministry of Health on July 5, the effective rate of Pfizer vaccine in preventing infection in Israel has dropped from 94.3% when Delta was not prevalent to 64%. On July 8, Pfizer stated in a statement that the protective effect of the Pfizer/BioNTech vaccine declined 6 months after vaccination, and it plans to apply to the FDA for enhanced injection in August.
The strange thing is that only three hours after the statement was issued, the U.S. Food and Drug Administration, the U.S. Centers for Disease Control and Prevention, and the U.S. National Health Service responded quickly and reiterated that the current vaccine is still highly effective against all mutant strains. Although strengthening needles need to be studied, there is no need to use them now. Afterwards, the WHO also issued the most severe criticism of the booster injection, suggesting not to carry out mixed vaccination, because there is not enough data for follow-up evaluation, and it reprimanded pharmaceutical companies to sell booster injections to developed countries that do not lack vaccines. It is out of “greed.”
In fact, the Chinese Communist Party and Western pharmaceutical companies themselves have developed experimental vaccines. The main purpose of the so-called booster injection is to compensate for the decline and insufficiency of vaccine effectiveness. However, in the absence of sufficient data on the effectiveness and side effects of previous vaccines, the Chinese Communist Party and pharmaceutical companies’ motivation to promote intensified injections is indeed doubtful. As for “immunity against specific pathogens will be higher after injection,” there is also a lack of strong data support. Moreover, the idea of “more immunizations, the better” is incorrect.
Therefore, we have to think about this question: Does the vaccine really work? Who will bear the responsibility for those who have problems after being vaccinated? Although the University of Hong Kong has conducted a mixed vaccination study and said that no serious adverse reactions have been seen, how many problems can the data of 50 people show? In fact, if you go beyond the problem of the vaccine itself, think about how the CCP virus came about, and listen to the warnings issued by compassionate people in the world: The virus mainly targets individuals, groups, organizations, governments, and countries that are closely related to the CCP. Understand that vaccines fundamentally cannot prevent the virus, and the prerequisite for staying away from the virus must be to stay away from the CCP.
Editor in charge: Putshan#
.